Key Points

• US IPO activity remained selective as Retension Pharmaceuticals and TRex Bio completed offerings, while Pine Tree Acquisition added a special-purpose acquisition company transaction to the week’s pricing activity.
• European listings demonstrated contrasting outcomes as Airtel Money raised approximately $703 million through a London share sale while Chaleit Holdings entered the AIM market with a smaller capital raise.
• Asian listing activity remained uneven, with ESWIN Computing debuting in Hong Kong and mainland Chinese markets reopening after the National Day holiday.

Global IPO Activity Reflects Selective Capital Deployment

The global IPO market entered the October 5–9 trading week with capital deployment concentrated in selected sectors and transactions rather than a broad expansion in issuance. In the United States, biotechnology offerings accounted for two of the week’s conventional IPOs, while a special-purpose acquisition company completed a separate offering. European markets recorded both a substantial London share sale and a smaller AIM admission, illustrating differences in transaction scale and structure. In Asia, Hong Kong recorded a new listing as mainland Chinese exchanges resumed trading after a holiday closure. The VIX closed at 14.84 on October 9, below its October 5 close of 15.52, although lower volatility alone did not establish a broad improvement in IPO demand.

United States — Biotechnology Pricing Advances Amid Selective Demand

Three US IPOs priced during the week: TRex Bio (TRXB), Retension Pharmaceuticals (RTSN), and Pine Tree Acquisition Corp. (PAXGU). TRex Bio priced at $14 per share, raising approximately $116.7 million through an offering of 8.3 million shares. Its stock finished the week at its IPO price. Retension Pharmaceuticals priced an upsized offering at $12 per share, raising approximately $45 million through 3.8 million shares, and ended its first trading session approximately 12% below the offer price. Pine Tree Acquisition priced a $100 million offering at $10 per unit and finished flat against that price. Together, the transactions represented approximately $261.7 million in gross proceeds. Meanwhile, DayOne Data Centers filed for a US IPO, bringing a potentially large data-center transaction into the pipeline. The week also included additional registration activity and the withdrawal of Siyata Mobile’s proposed Nasdaq direct listing, underscoring the distinction between new filings, completed IPOs, and alternative listing routes.

Europe — London Share Sales Expand the Range of Listing Outcomes

European activity featured two materially different transactions. Airtel Money began trading on the London Stock Exchange’s Main Market on October 9 after selling 270 million existing shares at £1.96 each. The transaction raised approximately $703 million and valued the business at around $7 billion. Shares closed at £1.93, slightly below the offer price. Because the offering involved existing shares, the proceeds primarily accrued to selling shareholders rather than representing new capital raised by the company. Chaleit Holdings was admitted to AIM on October 7 at an issue price of £0.50 per share. The transaction generated approximately £2.1 million in gross proceeds across the offering and related share sales, with the company raising a smaller amount directly through newly issued shares. Separately, Refresco was reported to be considering a potential listing in the United States or Europe at a valuation exceeding $10 billion. These developments highlighted a market in which transaction structure and issuer readiness remained central to execution.

Asia — Hong Kong Records a Listing as Mainland Trading Resumes

Hong Kong recorded the new listing of ESWIN COMPUTING (01256) on October 9. The listing added activity to the exchange during a week in which mainland Chinese markets were closed for the National Day holiday through October 7, with trading resuming on October 8. The holiday shortened the effective trading window for mainland exchanges and limited the basis for drawing conclusions about a sustained change in domestic issuance momentum. No additional major Asian IPO pricing was confirmed in the reviewed weekly data. Separately, Singapore-based DayOne Data Centers filed for a US listing, connecting Asian corporate expansion with the American capital market rather than a domestic Asian IPO venue. Its proposed transaction remained a pipeline development, not a completed offering. The distinction matters because cross-border filings can increase prospective issuance without immediately translating into local exchange activity or completed fundraising.

Israel — No Significant IPO Activity

No significant IPO activity was confirmed in Israel during October 5–9. The available weekly data did not identify a material Israeli IPO pricing, debut, or newly announced transaction that would support a more specific market assessment. Accordingly, the period provides insufficient evidence to characterize a meaningful shift in domestic listing demand or issuance conditions. This absence of confirmed activity should not be interpreted as proof that no companies were preparing transactions privately or considering future capital-market access. It indicates only that no significant Israeli IPO development was established in the reviewed period. For cross-border issuers and investors, the relevant question remains whether prospective listings progress into formally announced transactions as financing conditions and investor appetite evolve.

Next Session — Monitor Pricing Execution and Pipeline Conversion

The next trading sessions will test whether biotechnology issuers can sustain investor interest after mixed first-session performance and whether additional filed transactions advance toward formal pricing. Market participants will also monitor the development of DayOne Data Centers’ proposed offering and the pipeline of other US registrants. In Europe, subsequent trading in Airtel Money and progress among prospective issuers may provide further evidence of demand across different listing structures. Hong Kong’s post-holiday activity will offer a clearer view of near-term issuance momentum, while Israel remains without a confirmed significant IPO catalyst in the period reviewed.